Trial intelligence / Profile preview

ASA in Systemic Sclerosis

NCT03558854Phase 4Completed

Sponsor
Federal University of São Paulo
Start
Aug 2018
Primary completion
Sep 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of aspirin in systemic sclerosis (SSc), sponsored by Federal University of São Paulo. Started Aug 2018; status: completed.

02

Drugs

aspirin
03

Conditions

systemic sclerosis (SSc)

Beyond the preview

Go deeper on NCT03558854.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03558854.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call